min read

What changes when a European operation buys from a US-built testing partner, with SiPhox and Aniva as the worked example

SiPhox publishes more about its partner programme than almost anyone in at-home testing, and every published fact describes a United States operation. For a European buyer that changes the permits, the sample logistics, the catalogue breadth and the customer report.

Written by

Robert Jakobson

Published on

August 31, 2026

SiPhox Health publishes more detail about its partner programme than almost anyone else in at-home blood testing, which is why a European buyer comparing suppliers finds it early. The kit minimum, the panel contents, the turnaround figure and the API are all on the site, so a European clinic can evaluate it properly in an hour. That same detail makes the footing easy to check, because every published fact describes a United States operation. Everything stated about SiPhox below comes from siphoxhealth.com, read on 31 August 2026.

Five questions to ask any diagnostics supplier

The comparison is narrower than it looks, and these five questions do most of the work.

Which country and legal regime was this supplier built for, because the permits, the laboratory standards and the data agreements all belong to one country.
How does the sample physically get from your customer to a laboratory, and who holds the courier contract and the collection locations.
How wide is the catalogue against the product you want to sell in year two, not the one you will launch next month.
What do you commit to before the first sample is collected, meaning stock, notice period and exit terms.
What does your customer read afterwards, since the report is the only part of the chain they will ever see.

Ask both suppliers the same five questions in writing. Two answers to one question is a comparison, whereas two brochures are not.

Question one, the country each supplier was built for

SiPhox names HIPAA-compliant secure data delivery, states it will sign a business associate agreement with a Covered Entity, and names CLIA-certified and CAP-accredited laboratories. Its ordering model runs on requisitions from its own physician network, which the site states covers all 50 states. The registered company address on the partner pages is in Burlington, Massachusetts.

Every one of those is the right answer for a United States operation. HIPAA, CLIA and state requisition rules are exactly what a US buyer has to satisfy, and SiPhox publishes its answer to each of them.

They are not the answers a European legal review asks for. A clinic in Germany or the Netherlands is asked about GDPR, about a processing agreement with its supplier, about where the data is hosted, and about which laboratory standard the analysis runs under. Neither GDPR nor Europe appears on the SiPhox partner pages read on 31 August 2026.

Aniva names GDPR with an AVV included, infrastructure hosted in Germany, and an MDR-aware admin panel. Analysis is performed by an accredited laboratory partner, which holds ISO 15189 accreditation and operates under RiliBAEK. The partner contract carries anti-kickback clauses referencing Section 299a StGB and Section 31 of the model professional code. Contract wording does not by itself make an arrangement lawful, because the pricing and the substance decide that. Section 299b binds the paying side, so ask any supplier how its contract addresses that half. Diagnostics as a Service is sold to partners across Europe, while the consumer membership and the physical draw network are Germany only.

This is not a quality argument in either direction. It is a question of which legal regime a supplier was designed around, and a supplier can only be designed around one of them at a time.

Question two, how the sample reaches a laboratory

SiPhox publishes two blood collection formats for partners, which are the EasyDraw upper arm kit stated as available in the United States and a dried blood spot kit stated as available in Canada, alongside tabs for additional and custom tests. Both are mail-in formats, so both depend on a courier network and a laboratory in the customer's own country.

Aniva publishes six collection methods for partners across Europe, which are venous draw, saliva, capillary kit, stool, at-home kit and urine. It also publishes 25+ partner draw locations across Germany for supervised venous collection.

The venous draw is the item that cannot cross an ocean. It needs a room, a trained person and a courier who reaches the laboratory the same day, so it is a physical network and not a software feature. If your European programme will only ever post a kit back, this matters less to you, though you still need a European laboratory and a European courier at the other end.

Question three, panel size against catalogue size

These two numbers answer different questions and they are easy to confuse. SiPhox publishes named partner panels, and on 31 August 2026 those ran from 15 biomarkers on the Women's Health Panel to 62 on the Ultimate Health Panel. That figure tells you exactly what one kit gives one customer, which is genuinely useful.

Aniva publishes over 2,500 orderable parameters across eight modalities. Those modalities are clinical chemistry and endocrinology, nutrient status and immunology, genetics and transcriptomics, and proteomics and microbiome. That figure is a catalogue you build panels from, so it answers a question about year two.

Compare them by writing down the product you want to sell in eighteen months. A brand selling one metabolic panel will use perhaps twenty five markers under either supplier. A clinic that wants pharmacogenomics or a polygenic risk score needs that modality to exist in the catalogue before the conversation starts.

Question four, what you commit to

SiPhox publishes two different entry points. Its test panels page states a 30 kit minimum order, volume pricing discussed at 100 kits, and custom panels at 500 kits per month. Its partner FAQ states a 100 kit minimum to become an enterprise partner and custom panels from at least 1,000 kits. Ask them which one applies to your account. Kits bought in advance are held in the partner account as credits, so a brand can ship them one at a time.

That is an honest and low-risk way to start when your product is a kit. It is a harder fit when your product is a service, because you buy inventory before you know your panel mix, and a custom panel means committing to one of the two published minimums.

Aniva sells an integration rather than a stock order, with a custom panel builder in the console and monthly billing on one invoice. Aniva has not published a minimum order for the partner offering, so the commitment is agreed commercially rather than listed. Ask both suppliers for the minimum, the notice period and the exit terms in writing.

Question five, what your customer reads

Both companies deliver a branded result and both publish real detail about it. SiPhox names a white-label dashboard, biomarker trend analysis, progress tracking, branded emails and a custom domain, with results stated in 3 to 5 business days.

Aniva publishes a white-label customer dashboard with a plain-language explanation for every marker, a trend view across repeated panels, a customer-facing PDF, and your logo, colours and domain. The dashboard is published in German and English, with further languages available on request. Aniva states 24 hours for the core panel from sample pickup, measured from a different starting point than a business-day figure.

For a European operation the language row is the one to check first. The SiPhox platform features page names no dashboard language, so ask which languages it supports before you commit. A German customer reading an English explanation of their own ApoB will contact your support team, and that cost is paid by your staff every week.

What neither company publishes

Some of the decisive facts are on nobody's site, and that is normal. Neither company names a sample failure rate, a support response time, or the full commercial terms on the pages cited below.

SiPhox already answers one of these, because its partner pages state free replacements for failed tests. Ask the other supplier the same question in writing. Ask which laboratory performs each analysis and whether that can change without your agreement. Ask how long the data agreement runs and what happens to customer records when it ends.

The fair conclusion

SiPhox is the stronger choice for a business selling into the United States, and it is a reasonable choice for Canada, because it publishes a kit stated as available there. The physician network, the 50-state requisition model and the HIPAA framework are real assets, and they are the assets a US operation needs.

A European clinic or brand is not choosing a better version of the same product. You are choosing a different regulatory footing, a different courier and laboratory chain, and a different set of documents your counsel will read. Decide that question first, because everything else on the list only matters once a supplier can legally and physically serve the country your customers live in.

Notes and sources

Add blood testing to your business

Aniva provides the labs, the test kits, the shipping, the software and the data protection paperwork. You offer blood tests under your own brand. Tell us which tests you need and we will show you how it works.

Book a Demo